Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment (Q44545526)
Jump to navigation
Jump to search
scientific article published on 27 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment |
scientific article published on 27 June 2013 |
Statements
1 reference
Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment (English)
1 reference
1 reference
Deborah Cocorullo
1 reference
Laura Galli
1 reference
Alba Bigoloni
1 reference
Andrea Galli
1 reference
Giovanna Mignogna
1 reference
Alessia Carbone
1 reference
27 June 2013
1 reference
1 reference
Identifiers
1 reference